Ven Tan is a corporate partner in the firm’s Hong Kong office. Mr. Tan headed our Hong Kong office from 2005 to 2018 and served on the firm’s board of directors from 2011 to 2013. He has over 25 years of experience in a broad range of corporate and securities matters, including Hong Kong IPOs, dual listings, secondary offerings, corporate restructuring and private and public M&A transactions.
Mr. Tan is a frequent speaker at conferences on Hong Kong and China corporate legal issues. He has also been named as a leading lawyer for capital markets work and corporate/M&A by Chambers Global, Chambers Asia, IFLR 1000, and Asia Pacific Legal 500. He is also listed as a leading lawyer in the Hong Kong edition of Who’s Who Legal due to his work on the early overseas share offerings by major PRC state-owned enterprises such as Angang New Steel, Shanghai Hai Xing Shipping, Jilin Chemical, Beijing Yanhua Petrochemical, and Hainan Airlines.
Recent representative and market-leading transactions handled by Mr. Tan include the following. To view a more complete list, see Representative Matters:
Mr. Tan received his law degree with honors from Hull University, England, where he was editor of the Hull University Law Journal, and his Master of Law Degree (International Business Law) from King's College, London. He is qualified to practice in England and Wales, Hong Kong, and New York. He is fluent in English and Mandarin.
Golden Wheel TiandiRepresented Golden Wheel Tiandi in the first major Hong Kong IPO in 2013, raising HK$756 million. Golden Wheel is an integrated commercial and residential property developer, owner and operator with a proven track record in China. (2013)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Represented Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in its US$512 million initial public offering on the Hong Kong Stock Exchange, which was the third largest Hong Kong IPO of 2012 at the time of listing. UBS, CICC, JP Morgan, and Deutsche Bank acted as Joint Bookrunners and Joint Lead Managers. (2012)
Zall Development's US$195 Million IPO.Represented BNP Paribas Capital (Asia Pacific) Limited and BOCOM International (Asia) Limited as joint sponsors in the US$195 million initial public offering of Zall Development on the Hong Kong Stock Exchange. Zall Development is a leading developer and operator of large-scale, consumer product-focused wholesale shopping malls in China. (2011)
China Resources Power Holdings Company Ltd.'s US$699 Million Coal Asset Acquisition.Advised Hong Kong-listed China Resources Power Holdings Company Limited in its US$669 million acquisition of a 56% stake in Daning coal mine in Shanxi Province, northern China from Banpu Public Company Limited, a major Thailand-based natural resources company. The acquisition is part of CR Power's efforts to secure and expand it coal supply base for its power generation business. (2011)
China Gold International Resources Corp.'s US$309 Million IPO.Advised China Gold International Resources Corp. in its US$309 million initial public offering in Hong Kong. Citigroup Global Markets Asia Limited and BOCI Asia Limited acted as joint bookrunners and joint lead managers. China Gold is controlled by China’s biggest gold company. (2010)
China Zhengtong Auto Services Holdings Limited US$470 Million IPO.Advised JP Morgan and CCB International as joint bookrunners in the US$470 million initial public offering of China Zhengtong Auto Services Holdings Limited on the Hong Kong Stock Exchange. China Zhengtong is the second largest BMW dealer and a major 4S dealership group in China. (2010)
Chaowei Power Holdings Limited's US$70 Million IPO.Represented BNP Paribas Capital (Asia Pacific) Limited as sole book runner and lead manager in the US$70 million initial public offering of Chaowei Power Holdings Limited on the Hong Kong Stock Exchange. Chaowei is a leading lead-acid battery manufacturer in China and best known for its products sold under the CHILWEE brand. (2010)
Sinopharm Company Limited's US$1.1 Billion IPO.Represented the group of underwriters, which included China International Capital Corporation, Morgan Stanley Asia Limited, and Citigroup Global Markets Asia Limited, in the US$1.1 billion initial public offering of Sinopharm Company Limited in Hong Kong. Sinopharm is China's largest distributor of pharmaceuticals and is managed by state-owned China National Pharmaceutical Group. The IPO was awarded "Best IPO of the Year" by FinanceAsia and named as "Best Equity Deal" on IFR Asia's 2009 Roll of Honour. (2009)
HL Technology Group Limited's US$65 Million IPO.Advised HL Technology Group Limited in its US$65 million initial public offering on the Hong Kong Stock Exchange. Piper Jaffray Asia Securities Limited was the sole lead manager of the transaction. (2010)
Ruinian International's US$115 Million IPO.Represented HSBC and CCB International as joint lead managers in the US$115 million initial public offering of Ruinian International on the Hong Kong Stock Exchange. Ruinian is the largest manufacturer of amino acid-based nutritional supplements in China. (2010)
China South City’s US$400 Million IPO.Represented the group of underwriters, which included Merrill Lynch Far East Limited and BOCI Asia Limited in the US$400 million IPO and listing of shares of China South City Holdings Limited, a leading developer and operator of large-scale logistics and trade centers in China on the Hong Kong Stock Exchange (2009)
Angang Steel Company Limited's A and H Share Listing.Represented Angang Steel Company Limited in the unprecedented dual A- and H-share rights issue. The rights issue consisted of 195.8 million H-shares and $1.11 billion A-shares and raised approximately US$2.6 billion. Angang Steel Company is listed on the Hong Kong Stock Exchange and the Shenzhen Stock Exchange, and is China's second largest steel producer by production. (2007)
Asia Cement (China) Holdings Corporation US$275 Million IPO.Represented BNP Paribas and ABN AMBRO as joint lead managers of the US$275 million IPO of Asia Cement (China) Holdings on the Hong Kong Stock Exchange. (2008)
Solargiga Energy Holdings Limited's US$130 Million IPO.Represented BNP Paribas as sole book runner and lead manager of the US$130 million of IPO Solargiga Energy Holdings Limited on the Hong Kong Stock Exchange. Solargiga is the first solar power company to list in Hong Kong. (2008)
Pacific Online Limited's US$120 Million IPO.Represented BNP Paribas Capital (Asia Pacific) Limited and China International Capital Corporation (Hong Kong) Limited as joint lead managers in the US$120 million IPO of Pacific Online Limited on the Hong Kong Stock Exchange. (2007)
Kingsoft Corporation Limited's US$115 Million IPO.Represented Kingsoft Corporation Limited, a leading China-based software developer, distributor, and service provider in its US$115 million IPO on the Hong Kong Stock Exchange. (2007)
China Resources Power Holdings' US$775 Million Rights Issue.Represented China Resources Power Holdings (0836.HK) in its US$775 million rights share issue. (2009)
China Huiyuan US$345 Million IPO.Represented China Huiyuan in its US$345 million IPO on the Hong Kong Stock Exchange and the issuance of convertible bonds amounting to an approximate total of US$222.25 million from Group Danone, Warburg Pincus, and Holland Development Bank. China Huiyuan is the leading fruit and vegetable juice manufacturer in China, holding 42% of the market share for pure-fruit juice beverages. (2007)
Haitian International Holdings Limited's US$230 Million IPO.Represented BNP and UBS as joint lead managers in the US$230 million IPO by China-based Haitian International Holdings Limited on the Hong Kong Stock Exchange. Haitian International is the largest producer of plastic injection molding machines in the PRC. (2007)
Dalian Port (PDA) Company Limited's US$320 Million IPO.Represented Dalian Port (PDA) Company Limited in its US$320 million IPO on the Hong Kong Stock Exchange. (2006)
Jilin Chemical Industrial Company Limited US$470 Million Takeover Offer.Represented Jilin Chemical Industrial Company Limited in the US$470 million takeover offer made by PetroChina Company Limited, the controlling shareholder of Jilin Chemical, to purchase all of the outstanding H shares, American Depository Shares, and A shares of Jilin Chemical and the subsequent withdrawal of listing from the Hong Kong Stock Exchange, New York Stock Exchange, and Shenzhen Stock Exchange. This transaction was the first-ever voluntary offer for a company with listed domestic and foreign shares. (2005)
Venantius Tan was recommended as a leading individual for Equity Capital Markets by Legal 500 Asia Pacific 2017. He was also ranked as a leading individual in Hong Kong for Debt and Equity Capital Markets by IFLR1000 2017. Chambers Asia Pacific 2016 also listed him as a leading lawyer for Equity Capital Markets in China. He was highlighted as having “strong reputation owing to his many years of experience advising PRC businesses on cross-border offerings.”
©1996-2018 Morrison & Foerster LLP. All rights reserved.